Samsung to unveil retail innovations to enhance in-store experiences
Category: #retail  By Pankaj Singh  Date: 2020-01-14
  • share
  • Twitter
  • Facebook
  • LinkedIn

Samsung to unveil retail innovations to enhance in-store experiences

Samsung Electronics America, Inc. is reportedly set to highlight several innovations for brick-and-mortar retailers to reinvent and upgrade customers’ in-store experience at the 2020 NRF (Retail’s Big Show). The company is driven by its latest mobile devices, display, and behavior-sensing technologies and has been continuously providing distinctive retail experiences and attracting customers by joining hands with its partners.

Samsung has announced the inauguration of the Samsung booth #3219 from 12th to 14th of January 2020, at New York’s Jacob K. Javits Convention Center.

The next-generation image presentation ‘The Wall’ will be spotted by attendees right after their entrance, with outdoor and semi-indoor signage, as well as dual-sided OM46N-D. Inside the booth will be an entire network of display solutions, devices, and data analysis technologies to offer immersive in-store experiences.

According to Samsung’s Senior VP and General Manager, Harry Patz, the retail solutions portfolio of the company can help enrich and augment customer services provided by brick-and-mortar retailers, with its wide range of commercial display technologies.

Related products and solutions existing in Samsung booth include:

  • The Wall: It has aesthetic appeal with customized design by adding or removing LED screens without compromising on performance and quality.
  • MagicINFO Analytics: Driven by Brightics AI, it allows optimization and automation of advertisings on real-time integrated data and analyze customers’ behavior and big data to present relevant content.
  • Samsung Flip 2: It offers a versatile digital pen and paper collaboration to meet the demand in retail, corporate, and other sectors.
  • CTG7 curved monitor: It offers high-quality 27- as well as 32-inch panels with 2,560 x 1,440 resolution. With the help of CTG7, associates can avail real-time order placements.

Partner solutions that use various Samsung’s latest devices will also be displayed in the booth and improve retail and customer service management. Recently, Samsung also revealed the launch of Galaxy XCover Pro. These include next-gen barcode and RFID reading and associate-driven clienteling. Samsung also revealed partnerships with several companies such as Premier Mounts and Saatva, to collectively offer superior solutions.

Source credit:

https://news.samsung.com/us/samsung-nrf2020-retail-solutions-reinvent-customer-experience/



About Author

Pankaj Singh

Email: [email protected]   

Pankaj Singh

Pankaj Singh Develops content for Market Size Forecasters, Algosonline, and a couple of other platforms. A Post Graduate in Management by qualification, he worked as an underwriter in the UK insurance domain before deciding to switch his field of profession. With exp...

Read More

More News By Pankaj Singh

US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
US buys all of the global supply of Gilead’s COVID-19 drug remdesivir
By Pankaj Singh

While top-notch companies are racing to develop a vaccine for COVID-19, it looks like the United States has secured almost all of the world’s supply of interim drug remdesivir to treat patients with COVID-19.

...

Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
Potential COVID-19 vaccine by Bharat Biotech to enter clinical trials
By Pankaj Singh

Bharat Biotech International, a leading Indian biotechnology company, has reportedly announced that its potential coronavirus vaccine, Covaxin, has received Drug Controller General of India (DCGI) approval to start hum...

Seattle Genetics reveals positive data from tisotumab vedotin trial
Seattle Genetics reveals positive data from tisotumab vedotin trial
By Pankaj Singh

Seattle Genetics, Inc., a renowned biotechnology firm that focuses on developing antibody-based cancer treatments, has recently revealed positive topline data from its Phase 2 clinical trial (innovaTV 204) assessing ti...